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Aims: To compare the estimates and projections of type 2 diabetes mellitus (T2DM) pre-
valence in Saudi Arabia from a validated Markov model against other modelling estimates,
such as those produced by the International Diabetes Federation (IDF) Diabetes Atlas and the
Global Burden of Disease (GBD) project.
Methods: A discrete-state Markov model was developed and validated that integrates data
on population, obesity and smoking prevalence trends in adult Saudis aged 25 years to
estimate the trends in T2DM prevalence (annually from 1992 to 2022). The model was
validated by comparing the age- and sex-specific prevalence estimates against a national
survey conducted in 2005.
Results: Prevalence estimates from this new Markov model were consistent with the 2005
national survey and very similar to the GBD study estimates. Prevalence in men and women
in 2000 was estimated by the GBD model respectively at 17.5% and 17.7%, compared to 17.7%
and 16.4% in this study. The IDF estimates of the total diabetes prevalence were considerably
lower at 16.7% in 2011 and 20.8% in 2030, compared with 29.2% in 2011 and 44.1% in 2022 in
this study.
Conclusion: In contrast to other modelling studies, both the Saudi IMPACT Diabetes Fore-
cast Model and the GBD model directly incorporated the trends in obesity prevalence
and/or body mass index (BMI) to inform T2DM prevalence estimates. It appears that such a
direct incorporation of obesity trends in modelling studies results in higher estimates of
the future prevalence of T2DM, at least in countries where obesity has been rapidly
increasing.
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T2DM is one of the most common non-communicable diseases
in the world, and its levels are progressively increasing,
particularly in developing countries [1]. It imposes a heavy
burden on individuals and health care systems. The disease is
associated with severe complications (e.g. blindness, lower limb
amputations, and chronic renal failure) which affect health and
productivity [2]. In 2011, diabetes caused around 4.6 million
deaths globally in the 20–79 age group, and at least US$ 465
billion in healthcare expenditures, which was equivalent to 11%
of total healthcare expenditures in adults [3]. Therefore, it is
important for countries to have credible data on the trends in
T2DM prevalence and its likely future projections. These data
are required for proper health policy planning and resource
allocation for the prevention and control of T2DM.
The Kingdom of Saudi Arabia (KSA) is one of the largest and
wealthiest countries in the region of Middle East and North
Africa (MENA). It is a leading oil-producing country, and has
witnessed massive socioeconomic developments in the past
five decades with rapid urbanisation and changes in the
population lifestyles. KSA is now classified by the IDF to be
among the top 10 countries globally with the highest projected
prevalence of diabetes in 2011 (16.2%) and 2030 (20.8%) [1].
Furthermore, the prevalence of some risk factors for T2DM in
KSA (e.g. obesity) has also been estimated to be among the
highest in the world [4].
Epidemiological modelling is a valuable tool for estimation
and future prediction of T2DM prevalence. The IDF [1] and
other international modelling studies [5–9] have generated
estimates of the prevalence of diabetes in different countries
of the world, including KSA, at different time points. However,
for KSA, most of such estimates appear to noticeably under-
estimate the true situation, as they have been well surpassed
by the local ‘observed’ data.
We developed the ‘Saudi IMPACT Diabetes Forecast Model’ to
estimate the trends and likely future projections of T2DM in KSA,
based primarily on the trends in the prevalence of obesity and
smoking as risk factors. Obesity has been well recognised as one
of the most important risk factors for T2DM [10]. In addition,
smoking is not only a reflection of unhealthy lifestyle (with low
physical activity and unhealthy diet), but it has also been
recognised as an independent risk factor for T2DM in several
large prospective studies that have adjusted their results for
many potential covariates (e.g. obesity, physical activity, age, etc.)
[11]. We validated our model against local observed data from the
STEPS (STEPwise approach to non-communicable diseases
Surveillance) survey [12] in 2005. This study aims to provide a
detailed comparison of the estimates of T2DM prevalence in KSA
by the Saudi IMPACT Diabetes Forecast Model against the
estimates of the IDF Diabetes Atlas [1] and the GBD study [5].
2. Methods
2.1. The model
The Saudi IMPACT Diabetes Forecast Model is a discrete-state
Markov model, implemented in Microsoft Excel spreadsheets.It was originally designed for the MedCHAMPS project [13,14]
for use in middle and low income countries, where extensive
data on T2DM risk factors, prevalence, and complications may
not be available. It integrates information on the trends in the
adult Saudi population structure by age group and sex
(obtained from the Central Department of Statistics and
Information (CDSI) [15] and the United Nations (UN) popula-
tion estimates [16]), and the trends in the prevalence of two
risk factors for T2DM: obesity (BMI  30 kg/m2) and current
active smoking (obtained from local population-based sur-
veys). The model estimates the trends in prevalence of T2DM
in the Saudi adults aged 25 years during the 30-year period of
1992–2022. The age- and sex-specific prevalence of T2DM in
the starting year of modelling (1992) was obtained from a
nationwide population-based study, which used the WHO
1985 diagnostic criteria and oral glucose tolerance test (OGTT)
for diagnosis of T2DM [17].
Fig. 1 shows a simple illustration of the model structure.
The model assumes that the population is divided into three
discrete pools (health states): those who are obese, those who
are smokers, and those who are ‘healthy’ (i.e. non-obese, non-
smokers, and not having T2DM). Individuals can make
transitions from the three main health states or remain in
the same state during each modelling cycle (one year).
Individuals can make transitions to the (Diabetes) state (i.e.
they develop T2DM), or die due to other causes. Individuals in
the (Diabetes) state can die as a result of T2DM or due to other
causes. Individuals with T2DM cannot make transition back to
the three main states, assuming a zero remission rate.
The size of the (Obese) and (Smokers) states were
determined by the age- and sex-specific prevalence of obesity
and active smoking, as obtained from nationally-representa-
tive local surveys. Three surveys were used to obtain the
prevalence of obesity in 1992 [17], 1997 [18], and 2005 [12]. In
addition, two surveys were used to derive the prevalence of
active smoking in 1992 [19] and 2005 [12]. Data for missing
years were estimated through linear interpolation, while data
for future trends were estimated through linear extrapolation,
assuming similar rates of increase as that observed from
surveys. Fig. 2 demonstrates the trends in prevalence of
obesity and smoking in the adult Saudi men and women over
the modelling period (1992–2022), assuming a linear increasing
trends.
The potential overlaps between the model health states
were handled in three different ways. First, smoking pre-
valence was multiplied by obesity prevalence in order to
estimate the proportion of population who were both obese
and smokers. Then, such a proportion was subtracted from
the ‘original’ smoking prevalence, to leave in the (Smokers)
state only those individuals who were smokers but not obese.
Second, we estimated the number of individuals with T2DM
(in the Diabetes state) in whom the disease was assumed to be
‘caused’ by obesity as an exposure, through multiplying the
‘population attributable risk’ [20] by the size of (Diabetes) state.
Then, the number of such individuals was subtracted from the
total obese individuals in population, to leave in the (Obese)
state only those obese individuals who do not have T2DM.
Finally, we applied the same previous approach of the
population attributable risk, to leave in the (Smokers) states
only those people who are smokers, but not having T2DM.
Fig. 1 – Simple illustration of the structure of the Saudi IMPACT Diabetes Forecast Model.
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informed by the incidence of T2DM (incidence in ‘healthy’
people only), while the transition from (Obese) to (Diabetes)
states is informed by the incidence of T2DM  relative risk (RR) of
diabetes in obese individuals, and the transition from (Smokers)
to (Diabetes) states is informed by the incidence of T2DM  RR of
diabetes in smokers. Moreover, the transitions from any of the
three main states (Healthy, Obese, and Smokers) to the state of
(Deaths due to other causes) are informed by the total mortality
rate. On the other hand, transition from the (Diabetes) state to
the state of (Diabetes-related deaths) is informed by the case
fatality rate.
The model does not show explicit transitions from the
(Healthy) state to (Obese) or (Smokers), because of lack of data
needed to inform such transitions. In addition, as a simplifying
assumption, the prevalence of overweight (BMI 25–29.9 kg/m2)Fig. 2 – Trends in prevalence of obesity and smokingis not explicitly modelled, and we only considered the trends
in obesity prevalence.
The age- and sex-specific incidence and case fatality rate of
T2DM, in addition to the total mortality rate of population
were estimated using DISMOD 2 [21], which is a validated
generic disease model designed to supplement data on a
disease epidemiology by exploiting the causal relations
between the various available parameters. DISMOD 2 provides
‘internally-consistent’ estimates of diabetes incidence, case
fatality rate, and total mortality rate, based on a set of
differential equations that describe the disease process [21].
DISMOD 2 has been widely used by the WHO’s Global Burden
of Disease (GBD) Study and other modelling studies. DISMOD 2
provides an estimated incidence rate for the overall popula-
tion (i.e. for obese, smokers, non-obese and non-smokers).
However, assuming that the overall incidence of diabetes is a in the adult Saudi men and women (1992–2022).
Table 1 – Transition hazards used in the Saudi IMPACT Diabetes Forecast Model.
Transition parameter Data source Men – age group (years) Women – age group (years)
25–34 35–44 45–54 55–64 65–74 75+ 25–34 35–44 45–54 55–64 65–74 75+
Estimated incidence
rate of diabetes/1000
population
DISMOD 2 12.90 17.70 18.90 20.70 22.40 26.70 12.90 15.00 15.90 16.70 19.70 30.70
Estimated case fatality
rate (%)
DISMOD 2 0.15 0.39 0.67 1.20 1.35 2.10 0.16 0.43 0.62 0.96 1.90 4.62
Estimated total
mortality rate/1000
population
DISMOD 2 0.10 0.50 1.10 2.50 3.30 6.10 0.10 0.50 1.00 1.80 4.10 11.60
RR of diabetes if obese Guh et al. [10] 6.74 12.41
RR of diabetes if a
smoker
Willi et al. [11] 1.44 1.44
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Smokers) and non-exposed (Healthy) [22], we calculated the
incidence rate of diabetes among (Healthy) people only to
inform the transition between the (Healthy) state and
(Diabetes) state. We then adjusted this incidence rate by
applying the RRs of diabetes in obese and in smokers in order
to inform the transitions between the (Obese) and (Smokers)
states to (Diabetes) state.
The RR of diabetes in obese and in smoker individuals were
obtained from two recent systematic reviews and meta-
analyses [10,11]. Table 1 shows the age- and sex-specific
parameters used to set the transition probabilities in the
model.
We conducted two main methods of sensitivity analyses in
order to test the potential uncertainties around the model
parameters. First, we used the ‘analysis of extremes’ method
[23,24], where all model parameters (except population
structure) were conservatively set at 20% higher and 20%
lower values than the base-case scenario. The model was run
with this distribution of extreme values and the uncertainty
intervals (UIs) were estimated accordingly. Second, we used
the ‘scenario analysis’ method, where two reasonable scenar-
ios were assumed for the projected obesity prevalence. For
scenario 1, we assumed that the obesity trends would continue
to increase at the same annual rate as that observed from the
national surveys. In scenario 2, we assumed that the projected
obesity trends would be ‘capped’ at the highest ‘observed’
value in any age group for each sex separately. The highest
observed value for obesity prevalence in men was 34.5% in
those aged 35–44 years, while in women was 58.8% in the age
group 45–54 years. Therefore, the capping point was assumed
to be 35% in men and 60% in women.
2.2. Comparison with other models
We compared our model estimates with those recently
published by two independent modelling exercises, which
generated estimates and projections of T2DM prevalence in a
large number of countries around the world, including KSA.
2.2.1. The IDF Diabetes Atlas, fifth edition [1,25]
The IDF used logistic regression to model diabetes prevalence
rates in KSA, which were derived from five national popula-
tion-based surveys. The smoothed age- and sex-specific
prevalences were then applied to the national populationdistribution for the years 2011 and 2030 (using the UN
population estimates and the world population distribution)
to estimate national prevalence of diabetes. The IDF metho-
dology used changes in age, sex and urbanisation as covariates
for estimating diabetes prevalence.
2.2.2. The GBD model [5]
The GBD study (Global Burden of Metabolic Risk Factors of
Chronic Diseases Collaborating Group (Blood Glucose)) used
three national population-based surveys of T2DM preva-
lence in KSA [12,17,26] and used a multi-level statistical
approach (Bayesian hierarchical modelling) to model the
trends in fasting plasma glucose (FPG) and T2DM prevalence
in adults aged 25 years. The estimates were informed by
several country-level covariates. These covariates were
national income (natural logarithm of the per-head gross
domestic product), urbanisation (proportion of population
that lived in urban areas), age-standardised mean BMI (from
a previous GBD systematic analysis of country data [4]), and
national availability of multiple food types for human
consumption (from the food balance sheets of the Food
and Agriculture Organisation (FAO) of the UN). The pre-
sented estimates were age standardised to the WHO
reference population.
3. Results
The prevalence of T2DM among the Saudi population aged 25
years is estimated to rise substantially from 8.5% (UI: 6.8–
10.2%) in 1992 to 31.4% (UI: 25.5–37.0%) in 2013 and 44.1% (UI:
35.4–52.5%) by 2022, assuming that the observed prevalence
rates of both smoking and obesity will continue to increase. In
comparison, the prevalence of T2DM is estimated to increase
to 30.8% (UI: 25.2–36.2%) in 2013 and 39.5% (UI: 32.5–45.9%) by
2022, assuming capped obesity trends at 35% in men and 60%
in women. The estimated number of people with T2DM in KSA
will increase substantially from around 555,000 in 1992 to
approximately 7.4 million by 2022, assuming a continuing
increase of obesity levels, and nearly 6.6 million, assuming
capped obesity levels.
We compared the estimates of T2DM prevalence in KSA
from the Saudi IMPACT Diabetes Forecast Model against the
estimates of the IDF Diabetes Atlas (fifth edition) and the GBD
Study (Table 2).
Table 2 – Comparison of the Saudi IMPACT T2DM Forecast Model against the IDF (2011) model and the GBD (2011) model.
IDF (2011) [1,25] GBD (2011) [5] Saudi IMPACT Diabetes
Forecast Model
Estimated DM prevalence
in Saudi Arabia (%)
2011 Total: 16.2 2000 Males: 17.5
Females: 17.7
2000 Males: 17.7
Females: 16.4
Total: 17.2
2030 Total: 20.8 2008 Males: 22.0
Females: 21.7
2008 Males: 26.7
Females: 24.7
Total: 25.9
2011 Males: 29.8
Females: 28.1
Total: 29.2
2022 Males: 41.3
Females: 47.7
Total: 44.1
Age of study population
(years)
20–79 25+ 25+
Main data sources for DM
prevalence in Saudi Arabia
Al-Nuaim et al. [31]
El-Hazmi et al. [32]
Warsy and El-Hazmi [17]
Al-Nozha et al. [26]
WHO STEPS [12]
Warsy and El-Hazmi [17]
Al-Nozha et al. [26]
WHO STEPS [12]
Warsy and El-Hazmi [17]
(for starting year
prevalence)
WHO STEPS [12] (for
validation)
Estimation methodology Logistic regression
modelling
Complex multi-level
Bayesian hierarchical
modelling
Markov modelling
Covariates used for
estimating DM prevalence
 Urbanisation
 Ageing
 National income
 Urbanisation
 National availability of
multiple food types
 Age-standardised mean
BMI
 Trends in population
structure
 Trends in obesity
prevalence
 Trends in smoking
prevalence
 Estimated incidence
of T2DM
 Estimated case-fatality
rate
 Evidence-based estimates
of RRs for transition
probabilities
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[1,25]
The Saudi IMPACT Diabetes Forecast Model estimated the
total T2DM prevalence in the Kingdom (in adults aged 25
years) at 29.2% in 2011 and 44.1% in 2022 (assuming a
continuing linear increase in obesity trends ‘‘scenario 1’’), or
at 28.9% in 2011 and 39.5% (assuming capping of future obesity
trends ‘‘scenario 2’’). In comparison, the IDF has estimated the
prevalence of diabetes in KSA in adults aged 20–79 years at
16.2% in 2011 and 20.8% in 2030.
3.2. Comparison with the GBD estimates [5]
The Saudi IMPACT Diabetes Forecast Model estimated the
prevalence of diabetes in KSA among adult men and women
respectively as follows: 17.7% and 16.4% in 2000, and 26.7% and
24.7% in 2008. The model results for 2000 and 2008 were the
same with assuming a continuing linear increase (scenario 1),
or capping (scenario 2) of obesity trends. On the other hand,the estimates of the GBD model for men and women
respectively were 17.5% and 17.7% in 2000, and 22.0% and
21.7% in 2008.
4. Discussion
We developed and validate the Saudi IMPACT Diabetes
Forecast Model, which is a Markov model with relatively
few data input requirements. The model might be most
suitable for use in less developed settings with limited data on
T2DM. In addition to the demographic trends, the model also
used the trends in two risk factors for T2DM in KSA, as well as
literature-derived transition hazards. This study presents a
comparison between the results from this model against that
of the IDF Diabetes Atlas (fifth edition) [1] and the GBD study
[5].
In general, reliability and accuracy of T2DM prevalence
estimates are highly dependent on the data sources used in
modelling process and the model structure and methodology.
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estimates may be difficult, as different models often utilise
different data sources, apply different methodologies for
estimation and projections, and use different assumptions.
Furthermore, Danaei et al. [5] reviewed the available global
diabetes estimates and reported some other potential reasons
for variations in their results. For instance, the definition of
diabetes varied in different studies, as diagnostic criteria are
repeatedly changeable over time. In addition, studies were
different in their populations of interest, and some of them
used data sources with subnational samples, regarding them
as equally representative of national populations. This could
lead to biased results, as those specific subnational groups
might differ from the general populations in many aspects
such as prevalence of some risk factors for diabetes.
This study revealed that the Saudi IMPACT Diabetes
Forecast Model resulted in significantly higher estimates
and projections of T2DM prevalence in KSA than that
estimated by the IDF for 2011 and 2030 [1]. These considerable
differences between the two studies could be mainly attrib-
uted to the different methods of modelling of T2DM
prevalence and the covariates used for that purpose. Accord-
ing to the IDF, the estimation approach was deliberately kept
simple and conservative. The IDF model used logistic regres-
sion method and based its predictions for 2030 on predicted
demographic changes (urbanisation and ageing). Moreover,
the IDF model did not attempt to directly account for the
effects of changes in T2DM risk factors (e.g. obesity). The IDF
has acknowledged this as a limitation which was likely to
result in underestimation of T2DM prevalence if the levels of
obesity and other risk factors continue to rise [1].
Also, several previous modelling studies [6–9] resulted in
lower estimates and projections of diabetes prevalence in KSA
at different time points than the Saudi IMPACT Diabetes
Forecast Model (Table 3). Shaw et al. [6] and Wild et al. [7] used
local population-based surveys (also used by the IDF and GBD
models) as data sources of diabetes prevalence in KSA. On the
other hand, the oldest two studies (King et al. [8] and Amos
et al. [9]) used old data from Oman [27] (a neighbouring country
to KSA with similar socioeconomic characteristics) and
extrapolated such data to KSA. In general, all these four
modelling studies used only demographic changes and level of
urbanisation as informants of diabetes prevalence estimates
and projections.
On the contrary, the Saudi IMPACT Diabetes Forecast
Model utilised a different estimation approach (Markov
modelling). It used only the prevalence of T2DM for the
starting year (1992) along with the demographic trends of the
Saudi population (1992–2022) and the trends in prevalence of
two risk factors (obesity and smoking) over the same 30-year-
period. In addition, the model used a number of transition
parameters, such as the estimated incidence of T2DM, case
fatality rate, general mortality and evidence-based RRs. The
Saudi IMPACT Diabetes Forecast Model used published
nationally representative, population-based studies to obtain
data on the prevalence of obesity and smoking in KSA,
considering two reasonable scenarios of the future obesity
trends.
The results of the GBD model [5] and the Saudi IMPACT
Diabetes Forecast Model are very comparable, in spite ofdifferences in the general methods of estimation. This
similarity in results of the two models could be attributed
primarily to the several covariates used in both models to
estimate T2DM prevalence. In contrast to the other models
which used only ageing and level of urbanisation as
covariates, the GBD model incorporated more covariates to
inform its estimates. However, among all these covariates,
mean BMI is likely to have the most important contribution to
the higher estimates of the GBD model than that of the IDF
model; because mean BMI could serve as a ‘direct’ informant
of the trends in obesity levels. Another GBD modelling study
for trends in the global BMI [4] showed that the estimated
mean BMI in Saudi Arabia followed a linear increase between
1980 and 2008. The estimates of mean BMI (kg/m2) in men and
women in Saudi Arabia were respectively as follows: 25.0
(uncertainty interval (UI): 23.8–26.3) and 26.3 (UI: 24.8–27.8) in
1980, 25.9 (UI: 25.6–26.2) and 27.3 (UI: 26.9–27.8) in 1990, 27.0
(UI: 26.6–27.4) and 28.5 (UI: 28.0–29.0) in 2000, and 27.9 (UI: 27.2–
28.6) and 29.6 (UI: 28.7–30.5) in 2008. Furthermore, the GBD
estimates showed that the region of ‘North Africa and Middle
East’ has witnessed the largest increase in mean BMI in men
and women between 1980 and 2008 after the region of
‘Oceania’. Saudi Arabia was among the top countries with
the highest increase in mean BMI within its region [4].
Country-specific estimates of the prevalence of obesity
(BMI  30 kg/m2) were not reported. However, the region of
‘North Africa and Middle East’ had the seventh (among the 21
GBD regions of the world) highest prevalence of obesity in
men, and the second highest in women between 1980 and
2008. In men, the estimated prevalence of obesity in that
region increased substantially from <10% in 1980 to 20–30% in
2008. On the other hand, obesity prevalence in women
increased from 10–20% in 1980 to 30–40% in 2008 [4]. Taking
that into account, the trends in obesity prevalence seems then
to be a better option when modelling the future burden of
T2DM. The Association of Public Health Observatories (APHO)
Diabetes Prevalence Model [28] is a recent consistent example
that reported similar variations in the estimated prevalence of
diabetes when compared to other models. The APHO Diabetes
Prevalence Model used the trends in overweight and obesity in
England to estimate diabetes prevalence, which was approxi-
mately one third higher than that estimated by the IDF for
2010.
The Saudi IMPACT Diabetes Forecast Model offers to the
health policy planners in KSA robust and validated estimates
and projections of the burden of T2DM, and shows that the
currently high levels of the disease are expected to continue
increasing during the next decade, even assuming some
degree of levelling off of obesity trends. Therefore, there is an
urgent need for applying effective, aggressive and multi-
sectoral prevention measures to promote healthy diet,
physical activity, and smoking cessation. It is recommended
to improve public awareness to increase consumption of fruit
and vegetables, restrict consumption of fat and sugar,
practice a regular physical activity, and quit tobacco smoking
[29,30]. It is also important to establish (or maintain) relevant
legislation to enforce food industry to make clear and
informative food labelling, to incorporate physical education
into curriculums at girls schools, to strictly prohibit smoking
at public and work places, and to increase tobacco prices and
Table 3 – Comparison of the Saudi IMPACT T2DM Forecast Model against other modelling studies.
Shaw et al. [6] Wild et al. [7] King et al. [8] Amos et al. [9] Saudi IMPACT
Diabetes
Forecast Model
Estimated DM prevalence
in Saudi Arabia (%)
2010 Total: 13.6 2000 Total: 6.2 1995 Total: 8.7 1995 Total: 10.0 1995 Total: 11.1
2030 Total: 17.0 2030 Total: 8.1 2000 Total: 9.1 2000 Total: 12.0 2000 Total: 17.2
2025 Total: 10.1 2010 Total: 13.8 2010 Total: 28.1
2022 Total: 44.1
Age of study population
(years)
20–79 20+ 20+ 20+ 25+
Main data sources for
DM prevalence
in Saudi Arabia
Al-Nuaim et al. [31]
El-Hazmi et al. [32]
Al-Nozha et al. [26]
El-Hazmi
et al. [32]
Asfour et al. [27]
(Study from Oman)
El-Hazmi et al. [33]
Asfour et al.
[27](study
from Oman)
Warsy and
El-Hazmi [17]
(for starting
year prevalence)
WHO STEPS [12]
(for validation)
Estimation methodology Logistic regression
modelling
DISMOD 2 Age-specific
diabetes
prevalence
estimates were
applied to UN
population
estimates and
projections
Country-specific
diabetes
prevalence data
were applied to
the corresponding
national age
distribution
Markov modelling
Covariates used for
estimating DM
prevalence
 Demographic
changes
 Urbanisation
 Demographic
changes
 Urbanisation
 Trends in
population
size and
age structure
 Urbanisation
 Level of
economic
development
(GNP per capita)
 Urbanisation
 Trends in
population
structure
 Trends in obesity
prevalence
 Trends in
smoking
prevalence
 Estimated
incidence
of T2DM
 Estimated
case-fatality rate
 Evidence-based
estimates of RRs
for transition
probabilities
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primary prevention measures which aim to reduce the
prevalence of T2DM, it is also recommended to implement
mass screening programmes to diagnose those people with
‘occult’ disease for early treatment and prevention of disease
progression [29,30].
5. Conclusion
The Saudi IMPACT Diabetes Forecast Model and the GBD
model produced comparable estimates of T2DM prevalence
in Saudi Arabia, as both models directly incorporated the
trends in obesity prevalence and/or BMI to inform the
estimates. In contrast, the IDF and other modelling studies
relied solely on demographic trends and urbanisation as
covariates, and produced lower estimates of T2DM preva-
lence in Saudi Arabia. Hence, it appears that the direct
incorporation of obesity trends (as a strong predictor of
T2DM) in modelling studies results in higher estimates of thefuture prevalence of T2DM, particularly in countries and
regions with high levels of and increasing trends in obesity
prevalence.
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